There were 1,017 press releases posted in the last 24 hours and 356,706 in the last 365 days.

Exclusive live learning lab on peptide development and manufacturing at SMi's 3rd Peptides Event

3rd Peptides Event

Registration is now live for SMi Group's 3rd Peptides Conference which takes place in London on 6th - 7th July at the Holiday Inn Kensington Forum.

The live learning lab will also demonstrate a life cycle approach to peptide API manufacturing including process and regulatory dimensions.
— SMi Group
LONDON, LONDON, UNITED KINGDOM, March 24, 2016 /EINPresswire.com/ -- The global peptide therapeutics market is expected to reach a value of US$23.7B by 2020 as a result of their efficacy treating a huge array of conditions including cancer, metabolic disorders, nervous system disorders and gastrointestinal disorders among others. As such, further research has been done to develop a rich pipeline of novel peptides.

SMi’s 3rd Peptides Conference will explore the latest innovations in pre-clinical peptide development essential to the advancement of next generation peptides via case studies and presentations from MedImmune, Bachem, Bicycle Therapeutics, Sanofi-Aventis, Ipsen, Protagonist Therapeutics, and many more.

Just one of the highlights of this year's conference is an interactive session hosted by Vincent R. Bille, Founder and Managing Director of Marble Pharma Consult. This live learning lab entitled “Strategy for successful GMP peptide development, scale-up and manufacturing” will provide insights related to process and analytical development and management of external supply operations. It will also demonstrate a life cycle approach to peptide API manufacturing including process and regulatory dimensions.

Peptides 2016 will bring together a global network of experts including
• Lutz Jermutus, Senior Director, P&D & Product Development Team Leader, MedImmune
• Dan Teufel, Head of Chemistry, Bicycle Therapeutics
• Leila Hassani-Beniddir, Senior Scientist-Novel drug delivery technologies, Ipsen Limited
• Mathias Schoffrath, Group Leader Chromatography, Sanofi-Aventis
• Saif Shubber, Scientist, MedImmune
• Ashok Bhandari, Vice President, Chemistry, Protagonist Therapeutics
• Gary Bembridge, Director of Scientific Affairs Immunology, Abzena

A complete list of speakers and their topics can be downloaded on the event website.

For those who are interested in attending, a £500 early bird saving is currently available online which expires on 31st March. Visit http://www.peptidesevent.com for further details.

3rd Peptides Conference
6-7 July 2016
Holiday Inn Kensington Forum, London UK
www.peptidesevent.com

--- END ---
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Honey de Gracia
SMi
2078276102
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.